These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 36921730)
1. Exploring the reprogramming potential of B cells and comprehending its clinical and therapeutic perspective. Rani R; Nayak M; Nayak B Transpl Immunol; 2023 Jun; 78():101804. PubMed ID: 36921730 [TBL] [Abstract][Full Text] [Related]
2. Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα. Bueno C; Sardina JL; Di Stefano B; Romero-Moya D; Muñoz-López A; Ariza L; Chillón MC; Balanzategui A; Castaño J; Herreros A; Fraga MF; Fernández A; Granada I; Quintana-Bustamante O; Segovia JC; Nishimura K; Ohtaka M; Nakanishi M; Graf T; Menendez P Leukemia; 2016 Mar; 30(3):674-82. PubMed ID: 26500142 [TBL] [Abstract][Full Text] [Related]
3. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Hanna J; Markoulaki S; Schorderet P; Carey BW; Beard C; Wernig M; Creyghton MP; Steine EJ; Cassady JP; Foreman R; Lengner CJ; Dausman JA; Jaenisch R Cell; 2008 Apr; 133(2):250-64. PubMed ID: 18423197 [TBL] [Abstract][Full Text] [Related]
4. Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Eminli S; Foudi A; Stadtfeld M; Maherali N; Ahfeldt T; Mostoslavsky G; Hock H; Hochedlinger K Nat Genet; 2009 Sep; 41(9):968-76. PubMed ID: 19668214 [TBL] [Abstract][Full Text] [Related]
5. C/EBPα poises B cells for rapid reprogramming into induced pluripotent stem cells. Di Stefano B; Sardina JL; van Oevelen C; Collombet S; Kallin EM; Vicent GP; Lu J; Thieffry D; Beato M; Graf T Nature; 2014 Feb; 506(7487):235-9. PubMed ID: 24336202 [TBL] [Abstract][Full Text] [Related]
6. Cellular Ontogeny and Hierarchy Influence the Reprogramming Efficiency of Human B Cells into Induced Pluripotent Stem Cells. Muñoz-López Á; van Roon EH; Romero-Moya D; López-Millan B; Stam RW; Colomer D; Nakanishi M; Bueno C; Menendez P Stem Cells; 2016 Mar; 34(3):581-7. PubMed ID: 26850912 [TBL] [Abstract][Full Text] [Related]
7. Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitors. Ramos-Mejía V; Montes R; Bueno C; Ayllón V; Real PJ; Rodríguez R; Menendez P PLoS One; 2012; 7(4):e35824. PubMed ID: 22545141 [TBL] [Abstract][Full Text] [Related]
8. Heterokaryon-based reprogramming of human B lymphocytes for pluripotency requires Oct4 but not Sox2. Pereira CF; Terranova R; Ryan NK; Santos J; Morris KJ; Cui W; Merkenschlager M; Fisher AG PLoS Genet; 2008 Sep; 4(9):e1000170. PubMed ID: 18773085 [TBL] [Abstract][Full Text] [Related]
10. Efficient genetic reprogramming of unmodified somatic neural progenitors uncovers the essential requirement of Oct4 and Klf4. Di Stefano B; Prigione A; Broccoli V Stem Cells Dev; 2009 Jun; 18(5):707-16. PubMed ID: 18724799 [TBL] [Abstract][Full Text] [Related]
11. Induction of Human Naïve Pluripotent Stem Cells from Somatic Cells. Onfray C; Tan JP; Kilens S; Liu X; Polo J; David L Methods Mol Biol; 2022; 2416():39-51. PubMed ID: 34870829 [TBL] [Abstract][Full Text] [Related]
12. Tissue-Restricted Stem Cells as Starting Cell Source for Efficient Generation of Pluripotent Stem Cells: An Overview. Sundaravadivelu PK; Raina K; Thool M; Ray A; Joshi JM; Kaveeshwar V; Sudhagar S; Lenka N; Thummer RP Adv Exp Med Biol; 2022; 1376():151-180. PubMed ID: 34611861 [TBL] [Abstract][Full Text] [Related]
13. Direct reprogramming into desired cell types by defined factors. Ieda M Keio J Med; 2013; 62(3):74-82. PubMed ID: 23801083 [TBL] [Abstract][Full Text] [Related]
14. Advances in reprogramming somatic cells to induced pluripotent stem cells. Patel M; Yang S Stem Cell Rev Rep; 2010 Sep; 6(3):367-80. PubMed ID: 20336395 [TBL] [Abstract][Full Text] [Related]
16. A Versatile In Vivo System to Study Myc in Cell Reprogramming. Senís E; Mosteiro L; Grimm D; Abad M Methods Mol Biol; 2021; 2318():267-279. PubMed ID: 34019296 [TBL] [Abstract][Full Text] [Related]
17. Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4. Wang L; Huang D; Huang C; Yin Y; Vali K; Zhang M; Tang Y Stem Cell Res; 2017 Dec; 25():88-97. PubMed ID: 29125994 [TBL] [Abstract][Full Text] [Related]
18. NKX3-1 is required for induced pluripotent stem cell reprogramming and can replace OCT4 in mouse and human iPSC induction. Mai T; Markov GJ; Brady JJ; Palla A; Zeng H; Sebastiano V; Blau HM Nat Cell Biol; 2018 Aug; 20(8):900-908. PubMed ID: 30013107 [TBL] [Abstract][Full Text] [Related]
19. Attempting to Convert Primed Porcine Embryonic Stem Cells into a Naive State Through the Overexpression of Reprogramming Factors. Park TY; Choi KH; Lee DK; Oh JN; Kim SH; Lee CK Cell Reprogram; 2018 Oct; 20(5):289-300. PubMed ID: 30277824 [TBL] [Abstract][Full Text] [Related]
20. Reprogramming of pancreatic beta cells into induced pluripotent stem cells. Stadtfeld M; Brennand K; Hochedlinger K Curr Biol; 2008 Jun; 18(12):890-4. PubMed ID: 18501604 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]